Pion supports drug development programs with in vitro scientific instruments, contract research, and equipment maintenance. All designed to support more informed, more accurate, more timely decision making. Pion’s range of scientific instruments and services provide innovative solutions to the challenges of in vivo prediction, phys chem analysis, dissolution, and more. Clients may access Pion’s expertise either through the purchase of our instruments, or by contracting with our laboratories to run screens, assays and analysis on their behalf. Please contact [email protected] or visit our website www.pion-inc.com Show more Show less
1996
Pion Inc. raised undisclosed on June 20, 2021
Investors: SFW Capital Partners